Published in Rev Infect Dis on June 13, 1981
Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev (2000) 3.69
The meningococcus and mechanisms of pathogenicity. Microbiol Rev (1982) 2.39
Immune complex associated complications in the subacute phase of meningococcal disease: incidence and literature review. Arch Dis Child (2003) 1.19
Clinical features of meningococcal arthritis: a report of four cases. Ann Rheum Dis (1985) 1.16
Arthritis related to systemic meningococcal disease: 34 years' experience. Eur J Clin Microbiol Infect Dis (2012) 1.05
Arthritis in adults with community-acquired bacterial meningitis: a prospective cohort study. BMC Infect Dis (2006) 1.04
Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens. Infect Immun (1983) 1.00
Comparative long-term adverse effects elicited by invasive group B and C meningococcal infections. Clin Infect Dis (2011) 0.98
Current status of meningococcal group B vaccine candidates: capsular or noncapsular? Clin Microbiol Rev (1994) 0.94
Group C Neisseria meningitidis as a Cause of Septic Arthritis in a Native Shoulder Joint: A Case Report. Case Rep Orthop (2011) 0.87
Meningococcal Meningitis. Med J Armed Forces India (2011) 0.87
Neisseria meningitidis serogroup B peritonitis associated with continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis (1998) 0.84
Fatal acute cellulitis due to Neisseria meningitidis. J Clin Microbiol (2003) 0.83
Immune complexes and the pathogenesis of meningococcal arthritis. Clin Exp Immunol (1985) 0.82
Immunogenicity of the meningococcal stress protein MSP63 during natural infection. Clin Exp Immunol (1993) 0.79
Isolated septic arthritis: meningococcal infection. J R Soc Med (2003) 0.78
Waldenström's disease complicated by recurrent meningococcal arthritis. J Clin Microbiol (2001) 0.78
Primary meningococcal arthritis leading to Neisseria meningitidies purpura fulminans. West J Emerg Med (2013) 0.78
Meningococcal septicaemia and meningitis: a rising tide. Br Med J (Clin Res Ed) (1988) 0.77
Immune complex reaction after successful treatment of meningococcal disease: an excellent response to IVIG. Rheumatol Int (2010) 0.75
Primary meningococcal arthritis associated with adult respiratory distress syndrome. Ann Rheum Dis (1990) 0.75
Primary Meningococcal Septic Arthritis of the Knee by Neisseria meningitidis Serotype Y. West Indian Med J (2014) 0.75
A very rare case of primary meningococcal arthritis in an adult male. Clin Case Rep (2014) 0.75
Neisseria meningitidis Serogroup C Causing Primary Arthritis in a Child: Case Report. Medicine (Baltimore) (2016) 0.75
Neisseria meningitidis Infecting a Prosthetic Knee Joint: A New Case of an Unusual Disease. Case Rep Infect Dis (2017) 0.75
Arthritis secondary to meningococcal disease: A case series of 7 patients. Medicine (Baltimore) (2017) 0.75
Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. J Infect Dis (1981) 3.28
Evidence for fluid volume depletion in hyponatraemic patients with bacterial meningitis. Acta Paediatr (1996) 2.60
Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA (1997) 2.29
Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis. Antimicrob Agents Chemother (1980) 2.27
Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis (1984) 2.02
Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants. J Pediatr (1981) 2.00
Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis. Am Rev Respir Dis (1989) 1.99
Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy. Pediatr Infect Dis (1987) 1.92
Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis. J Infect Dis (1988) 1.81
Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis. J Pediatr (1995) 1.73
Clinical pharmacology and efficacy of vancomycin in pediatric patients. J Pediatr (1980) 1.71
Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin Infect Dis (2000) 1.71
Novel Campylobacter-like organism resembling Helicobacter fennelliae isolated from a boy with gastroenteritis and from dogs. J Clin Microbiol (1993) 1.67
Single-dose pharmacokinetics of ceftriaxone in infants and young children. Antimicrob Agents Chemother (1982) 1.59
Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. J Pediatr (1979) 1.46
[Aseptic meningitis in pediatrics]. Schweiz Med Wochenschr (1991) 1.40
Multiple herpetic whitlow lesions in a 4-year-old girl: case report and review of the literature. Eur J Pediatr (2001) 1.26
Quinolone arthropathy in animals versus children. Clin Infect Dis (1997) 1.25
Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa. J Infect Dis (1986) 1.19
Melioidosis. J Pediatr (1982) 1.13
Invasive infection with Mycobacterium genavense in three children with the acquired immunodeficiency syndrome. Eur J Clin Microbiol Infect Dis (1993) 1.13
Diagnosis of acute haematogenous osteomyelitis and septic arthritis: 20 years experience at the University Children's Hospital Basel. Swiss Med Wkly (2001) 1.12
Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases. Pediatr Infect Dis J (1997) 1.07
Pyogenic arthritis of the sacroiliac joint in pediatric patients. Pediatrics (1980) 1.05
Occurrence and phenotypic properties of verotoxin producing Escherichia coli in sporadic cases of gastroenteritis. Eur J Clin Microbiol Infect Dis (1992) 1.02
Recrudescence and relapse in bacterial meningitis of childhood. Pediatrics (1981) 1.02
Brevibacterium casei sepsis in an 18-year-old female with AIDS. J Clin Microbiol (2000) 1.01
Properdin deficiency in a large Swiss family: identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n). Clin Exp Immunol (1999) 1.00
Nalidixic acid in children: retrospective matched controlled study for cartilage toxicity. Infection (1987) 0.98
An extended experience with cefuroxime therapy of childhood bacterial meningitis. Pediatr Infect Dis (1984) 0.97
Cefuroxime in bacterial meningitis. Arch Dis Child (1982) 0.94
Acute community-acquired diarrhea requiring hospital admission in Swiss children. Clin Infect Dis (2000) 0.93
Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Swiss Neonatal HIV Study Group. Eur J Pediatr (1992) 0.92
Pharmacology and efficacy of vancomycin for staphylococcal infections in children. Rev Infect Dis (1982) 0.91
Reversibility of lung function abnormalities in children with perennial asthma. J Pediatr (1983) 0.91
Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group. Pediatr Infect Dis J (1997) 0.90
Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients. J Infect Dis (1992) 0.89
A syndrome of primary combined immunodeficiency with microcephaly, cerebellar hypoplasia, growth failure and progressive pancytopenia. Eur J Pediatr (1994) 0.88
Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children. Neuropathol Appl Neurobiol (2006) 0.88
Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity. Pediatr Infect Dis J (2001) 0.88
Fibronectin-cleaving activity in bronchial secretions of patients with cystic fibrosis. J Infect Dis (1988) 0.88
Single-dose ceftriaxone kinetics in the newborn. Clin Pharmacol Ther (1985) 0.87
Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients. Antimicrob Agents Chemother (1996) 0.87
Brain abscess in childhood--long-term experiences. Eur J Pediatr (1991) 0.86
Chronic granulomatous disease: uptake and intracellular activity of fosfomycin in granulocytes. Pediatr Res (1985) 0.86
Immunization of noncolonized cystic fibrosis patients against Pseudomonas aeruginosa. J Infect Dis (1994) 0.85
[Seroprevalence of IgG antibodies against measles, mumps and rubella in Swiss children during the first 16 months of life]. Schweiz Med Wochenschr (2000) 0.85
Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients. Antimicrob Agents Chemother (1983) 0.84
[Herpes simplex virus type 1 and 2 in Switzerland]. Schweiz Med Wochenschr (2000) 0.84
Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants. Pediatr Infect Dis J (1996) 0.83
Intestinal cryptosporidiosis acquired from a cat. Infection (1990) 0.83
[Rotavirus gastroenteritis in infants and children. Results of a prospective study in the area of Geneva and Basel 1997/1998 (RoMoS). RoMoS Study Group]. Schweiz Med Wochenschr (1999) 0.83
Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalised children and adolescents. Eur J Clin Microbiol Infect Dis (2003) 0.82
Clinical evaluation of an octavalent Pseudomonas aeruginosa conjugate vaccine in plasma donors and in bone marrow transplant and cystic fibrosis patients. Antibiot Chemother (1971) (1991) 0.82
[Prevention of pneumococcal, meningococcal and Haemophilus influenzae type B infections in childhood]. Ther Umsch (1982) 0.82
[Antibiotic therapy of bacterial meningitis]. Ther Umsch (1984) 0.79
[TBE-immunoglobulins--a critical assessment of efficacy]. Schweiz Med Wochenschr (1994) 0.79
Reactive arthritis associated with Campylobacter enteritis. Pediatr Infect Dis (1983) 0.79
[Antibiotic treatment of urinary tract infections in hospitalized children]. Schweiz Med Wochenschr (1995) 0.78
Intraepithelial lymphocytes before and after gluten challenge in children with celiac disease. Am J Dis Child (1981) 0.78
Linkage analysis in properdin deficiency families: refined location in proximal Xp. Clin Genet (1992) 0.78
Which number of infecting bacteria is of clinical relevance? Infection (1983) 0.78
Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin. Acta Paediatr Scand (1986) 0.78
Screening for complement deficiency in bacterial meningitis. Acta Paediatr (1997) 0.78
[Congenital toxoplasmosis: pediatric approach. Consensus report of the Swiss infectious disease pediatricians]. Schweiz Med Wochenschr Suppl (1995) 0.77
The pharmacologic basis for moxalactam therapy for gram-negative enteric bacillary meningitis of infancy. Rev Infect Dis (1983) 0.77
Clinical experience with aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants. Pediatr Infect Dis J (1994) 0.77
Incidence and diagnosis of rotavirus infection in neonates: results of two studies. J Perinat Med (1990) 0.77
Mycobacterium genavense invasive infection in two children with AIDS: long-term followup. Eur J Pediatr (1995) 0.77
Sequential intravenous-oral amoxycillin/clavulanate (Augmentin) therapy in paediatric hospital practice. J Antimicrob Chemother (1987) 0.77
Acute encephalitis in Swiss children: aetiology and outcome. Eur J Paediatr Neurol (1998) 0.76
[Pneumothorax in cystic fibrosis]. Schweiz Med Wochenschr (1991) 0.76
Infantile chlamydial pneumonia--a review based on 115 cases. Eur J Pediatr (1982) 0.76
Meningitis caused by Ureaplasma urealyticum in a full term neonate. Pediatr Infect Dis J (1994) 0.76
High performance liquid chromatographic determination of moxalactam in human plasma and cerebrospinal fluid. Eur J Clin Pharmacol (1985) 0.75
Pharmacokinetics of moxalactam in neonates and young infants. Rev Infect Dis (1983) 0.75
Solubilization of immune precipitates by complement in the absence of properdin or factor D. FEBS Lett (1988) 0.75
[Simple and reliable detection of beta-hemolytic streptococci in throat swabs with the streptococcus-isocult]. Schweiz Med Wochenschr (1981) 0.75
[Possibilities and limits in the detection of nosocomial rotavirus infections]. Helv Paediatr Acta (1985) 0.75
Transient infection in human immunodeficiency virus type 1-exposed infants. Pediatr Infect Dis J (1996) 0.75
[Infectious diarrhea in childhood]. Helv Paediatr Acta (1983) 0.75
The cephalosporin compounds in severe neonatal infection. Eur J Pediatr (1984) 0.75
[Cystic fibrosis: current therapy. Antibiotics]. Schweiz Med Wochenschr Suppl (2000) 0.75
Pharmacologic basis for antimicrobial therapy of neonatal meningitis. Helv Paediatr Acta (1981) 0.75
[Phenylhydrargyrum boricum in glycerin (Glycero-Merfen) in young children: undesirable mercury resorption in mouth mucosa even when free of lesions]. Schweiz Med Wochenschr (1983) 0.75
[Special infections of the respiratory tract in children]. Schweiz Med Wochenschr (1985) 0.75
[Meningitis and sepsis in the newborn age: therapy concepts and antibiotic therapy]. Schweiz Rundsch Med Prax (1983) 0.75
Chemoprophylaxis of bacterial meningitis. J Antimicrob Chemother (1985) 0.75
Sputum penetration of fusidic acid in patients with cystic fibrosis. Eur J Pediatr (1982) 0.75
[Prospective comparison of miconazole gel and nystatin suspension in the treatment of oral candidiasis]. Schweiz Med Wochenschr (1983) 0.75
Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis. Infection (1982) 0.75
[Tick-borne meningoradiculitis--a form of spirochetosis]. Schweiz Med Wochenschr (1984) 0.75
Pharmacokinetics of a syrup formulation of amoxycillin-potassium clavulanate in children. J Antimicrob Chemother (1986) 0.75
Acquired immunodeficiency syndrome (AIDS) in pediatric patients. Case report and review. Helv Paediatr Acta (1985) 0.75
[Brainstem encephalitis and vesicular exanthema caused by Mycoplasma pneumoniae]. Schweiz Med Wochenschr (1984) 0.75
["Childhood illnesses" are still a concern. A conversation with Prof. Dr. Urs B. Schaad. Interview by Dr. Klaus Reinhardt]. Ther Umsch (1998) 0.75
Chemoprophylaxis for the prevention of bacterial meningitis. Infection (1984) 0.75
[Vaccination reactions and complications]. Ther Umsch (1983) 0.75
[Syndromes caused by staphylococcal toxins]. Schweiz Rundsch Med Prax (1985) 0.75
[Prospective evaluation of coagglutination and latex agglutination in the diagnosis of bacterial meningitis in childhood]. Schweiz Med Wochenschr (1986) 0.75